Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve Audited Financial Results (Standalone and Consoldiated) for the quarter and financial year ended 31 March 2026.
Suven Life Sciences: Board Meeting Intimation for Consideration Of Audited Financial Results (Standalone And Consoldiated) For The Quarter And Financial Year Ended 31 March 2026.
06-May-2026
Download PDF
Suven Life
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month